Literature DB >> 1704222

Vitronectin in the substratum of endothelial cells is cross-linked and phosphorylated.

D C Sane1, T L Moser, C S Greenberg.   

Abstract

Vitronectin (VN), previously shown to be a substrate for purified transglutaminases, was demonstrated in this study to be cross-linked when incubated with HUVEC and EAhy926 cells. The cross-linking was calcium-dependent and required that VN be plated at the substratum of the cells. These cells also phosphorylated VN, but in contrast to a previous study demonstrating a cAMP-dependent protein kinase in platelets, the phosphorylation of VN by was decreased with the addition of 1mM cAMP. The cross-linking of VN by endothelial cells demonstrates that the adhesion of these cells to VN is a dynamic process in which the substratum may be enzymatically altered. Furthermore, the modifications of VN by cross-linking and phosphorylation could modulate the functions of VN and influence events such as endothelial cell proliferation and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704222     DOI: 10.1016/0006-291x(91)91439-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta.

Authors:  I Nunes; P E Gleizes; C N Metz; D B Rifkin
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

2.  Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion.

Authors:  V Gentile; V Thomazy; M Piacentini; L Fesus; P J Davies
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

3.  Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.

Authors:  S Kojima; K Nara; D B Rifkin
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.